Quest Diagnostics Inc. (DGX) Updates Q3 Earnings Guidance
Quest Diagnostics Inc. (NYSE:DGX) issued an update on its third quarter earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $1.02-1.15 for the period, compared to the Thomson Reuters consensus estimate of $1.20, AmericanBankingNews.com reports. The company issued revenue guidance of $1.79 billion, compared to the consensus revenue estimate of $1.84 billion.
A number of research firms have recently commented on DGX. Analysts at Zacks reiterated a neutral rating on shares of Quest Diagnostics in a research note to investors on Tuesday. They now have a $65.00 price target on the stock. On a related note, analysts at Goldman Sachs Group Inc. raised their price target on shares of Quest Diagnostics from $66.00 to $71.00 in a research note to investors on Wednesday, October 2nd. They now have a buy rating on the stock. Finally, analysts at Craig Hallum initiated coverage on shares of Quest Diagnostics in a research note to investors on Thursday, September 19th. They set a buy rating on the stock. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and five have given a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and a consensus price target of $61.40.
Quest Diagnostics Inc. (NYSE:DGX) opened at 61.70 on Thursday. Quest Diagnostics Inc. has a 52-week low of $55.16 and a 52-week high of $64.76. The stock has a 50-day moving average of $60.98 and a 200-day moving average of $59.74. The company has a market cap of $9.371 billion and a P/E ratio of 18.83.
Quest Diagnostics (NYSE:DGX) last posted its quarterly earnings results on Thursday, July 18th. The company reported $1.06 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.10 by $0.04. The company had revenue of $1.82 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter in the prior year, the company posted $1.17 earnings per share. The company’s quarterly revenue was down 3.4% on a year-over-year basis. Analysts expect that Quest Diagnostics Inc. will post $4.34 EPS for the current fiscal year.
Quest Diagnostics Incorporated (NYSE:DGX)is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.